Skip to main content
Premium Trial:

Request an Annual Quote

International Workings

Not all collaborations are the same. NPR's Joe Palca reports that international collaborations are more likely to affect the wider scientific community.

Two ecologists — Stefano Allesina at the University of Chicago and the University of Florida's Emilio Bruna — became interested in whether there was a difference in what kind of journal the results from international collaborations were published in.

They thought that maybe "international collaboration and meeting and working with ecologists in other countries could be really beneficial to us as scientists," Bruna tells Palca.

Their team examined papers published in eight fields between 1996 and 2012 and reported in PLOS One earlier this year that the more countries listed among authors' affiliations, the better the papers did in terms of journal placement and citations.

"Your chances of getting into these top journals are much higher if you collaborate across nations," Allesina says. And then, he adds, citations rates, those articles have a higher impact that the typical articles in those journals because they are more highly cited.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.